Pressure BioSciences, Inc. is engaged in the development and sale of high-pressure technology-based instruments, consumables, and services for the life sciences and other industries worldwide. The Company's segments include Industrial, Consumer and Parent. Its Industrial segment contains the Ultra Shear Technology (UltraShear or UST), BaroFold Technology (BaroFold), and Pressure Cycling Technology (PCT) Platforms. Its products include Barocyclers, Barocycler Accessories, External Pressure Calibration Device Kit, MicroTubes for Barocyclers, MicroTube Accessories for Barocyclers, BaroShear K45, HUB High Pressure Generators and Accessories, HP Cell From ISS, RF1700 Mini Ultra-High Pressure Pump, SHREDDER SG3 and SHREDDER Tubes, and Service Contracts. Its Consumer segment represents the activity of Uncle Budâ€™s. Uncle Budâ€™s offers products direct-to-consumer online and through retail chains. Uncle Budâ€™s is engaged in hemp seed oil, cannabidiol (CBD), and the health and wellness industry.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data

Delayed OTC Markets Other stock markets 03:08:07 28/05/26 am AEST			5-day change	1st Jan Change
0.001200 ^USD	+100.00%		-.--%	+140.00%

08/02/25	Pressure BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
07/09/24	Pressure BioSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Market Cap	143K 124K 115K 107K 201K 13.73M 205K 1.37M 530K 6.62M 538K 527K 23.01M	P/E Ratio 2022	-0.81x	P/E Ratio 2023	-0.22x
Enterprise Value	22.95M 19.91M 18.36M 17.2M 32.14M 2.2B 32.81M 219M 84.78M 1.06B 86.15M 84.29M 3.68B	EV / Sales 2022	21.1x	EV / Sales 2023	15.5x
Free-Float	99.27%	Yield 2022 *	-	Yield 2023	-

08/02/25	Pressure BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
07/09/24	Pressure BioSciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
26/06/24	Pressure BioSciences, Inc. Partners with Vita-Forte to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray	CI
21/06/24	Pressure BioSciences, Inc. - Special Call
08/06/24	Pressure BioSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
07/06/24	Pressure BioSciences, Inc. Auditor Raises 'Going Concern' Doubt	CI
16/02/24	Pressure BioSciences, Inc. Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing	CI
06/02/24	CBH International LLC, Pressure BioSciences, Inc. - M&A Call
22/01/24	Pressure BioSciences, Inc. completed the acquisition of CBH International LLC.	CI
19/01/24	Pressure BioSciences, Inc. Receives Open Order Agreement from West Coast Manufacturing Partner	CI
11/01/24	Pressure BioSciences, Inc. entered into a definitive agreement to acquire CBH International LLC.	CI
05/01/24	Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies	CI
13/12/23	Pressure BioSciences, Inc. Announces the Publication of Pivotal Scientific Study in the Critical Field of Food Safety	CI

18/06/24	Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET	AQ
14/06/24	Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET	AQ
12/04/24	Uncle Bud’s Health and Wellness to Expand New Premium Collection with Novel Products for Sleep, Memory, Pain, Immunity, Feminine Hygiene, and Sexual Wellness	AQ
03/04/24	Pressure BioSciences’ Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”	AQ
27/02/24	Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.	AQ

Pressure BioSciences, Inc. Stock

Stocks

PBIO

US74112E2081

Advanced Medical Equipment & Technology

Valuation: Pressure BioSciences, Inc.

Chart: Pressure BioSciences, Inc.

Latest news : Pressure BioSciences, Inc.

Press Releases: Pressure BioSciences, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Pressure BioSciences, Inc.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Income Statement and Estimates

1 day	+100.00%
1 month	-76.00%
3 months	+140.00%
6 months	+100.00%
Current year	+140.00%

1 month	0		0
Current year	0		0.1
1 year	0		0.2
3 years	0		0.91
5 years	0		4.98
10 years	0		13.8

Manager	Title	Age	Since
Richard Schumacher CEO	Chief Executive Officer	75	16/04/2004
Alexander Lazarev CTO	Chief Tech/Sci/R&D Officer	61	03/04/2006
Edmund Ting CTO	Chief Tech/Sci/R&D Officer	72	24/04/2006

Director	Title	Age	Since
Richard Schumacher CHM	Chairman	75	01/01/1992
Jeffrey Peterson CHM	Chairman	70	08/08/2012
Michael Urdea BRD	Director/Board Member	73	08/02/2013

Date	Insider	Type	Main position	Quantity	% Market Cap.
27/09/24	Richard Schumacher	Others	Chief Executive Officer	22,878	0.0659%
27/09/24	Jeffrey Peterson	Others	Chairman	59,652	0.1719%
27/09/24	Alexander Lazarev	Others	Chief Technology Officer	18,863	0.0543%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PRESSURE BIOSCIENCES, INC.	+100.00%	-.--%	-72.73%	-99.86%	51.56K
THERMO FISHER SCIENTIFIC, INC.	-1.65%	-1.66%	+14.18%	-9.49%	179B
INTUITIVE SURGICAL, INC.	+0.61%	-1.06%	-20.68%	+32.12%	146B
DANAHER CORPORATION	-1.38%	-3.09%	-11.65%	-24.02%	130B
BOSTON SCIENTIFIC CORPORATION	-1.03%	-2.21%	-51.94%	-6.70%	71.85B
EDWARDS LIFESCIENCES CORPORATION	+0.48%	-1.23%	+14.45%	+0.94%	49.51B
SIEMENS HEALTHINEERS AG	-1.99%	-0.72%	-26.09%	-34.75%	45.25B
AGILENT TECHNOLOGIES, INC.	-2.03%	-6.84%	+7.67%	+8.74%	37.17B
WATERS CORPORATION	-0.97%	-4.33%	+4.08%	+40.18%	35.66B
GE HEALTHCARE TECHNOLOGIES INC.	+1.07%	+1.02%	-12.18%	-17.64%	29B
Average	+9.41%	+1.09%	-15.49%	-11.05%	72.35B
Weighted average by Cap.	-0.78%	+1.56%	-8.45%	-1.24%

	2022	2023
Net sales	1.73M 1.5M 1.38M 1.3M 2.42M 166M 2.47M 16.5M 6.39M 79.82M 6.49M 6.35M 278M	1.98M 1.72M 1.58M 1.48M 2.77M 189M 2.83M 18.87M 7.31M 91.28M 7.42M 7.26M 317M
Net income	-16.08M -13.95M -12.86M -12.05M -22.51M -1.54B -22.98M -153M -59.39M -742M -60.35M -59.05M -2.58B	-29.31M -25.44M -23.45M -21.97M -41.05M -2.81B -41.91M -280M -108M -1.35B -110M -108M -4.7B
Net Debt	20.53M 17.81M 16.42M 15.38M 28.74M 1.97B 29.34M 196M 75.83M 947M 77.05M 75.39M 3.29B	22.8M 19.79M 18.24M 17.09M 31.94M 2.18B 32.6M 218M 84.25M 1.05B 85.61M 83.76M 3.66B